Partnering is central to Noven’s growth strategy – so much so that the goal of benefiting industry partners is part of our company Mission. Collaborative, mutually-beneficial industry partnerships and other alliances helped establish Noven as a dynamic and growing company. For example, Novogyne Pharmaceuticals, our women’s health joint venture with Novartis Pharmaceuticals Corporation, is one of the longest running and most successful joint ventures in the industry. Alliances such as Novogyne helped us build the commercial infrastructure that we enjoy today, including fully-integrated product development, manufacturing and commercial sales capabilities. We are confident that our continued emphasis on establishing and fostering partnerships will mean further success for our partners and for Noven as we expand the population of patients who benefit from our products and technologies.
Noven seeks meaningful partnerships along a broad spectrum of potential transaction structures, including:
From our history of successful partnerships, we know that the key to success is for both parties to identify and commit to a shared vision with well-defined goals. We also know the importance of a streamlined business development process that emphasizes flexibility, focus, efficiency, and transparency in communications and dealings, with the goal of forming a creative “win-win” strategic alliance that benefits both parties.
And we know that even the strongest partnerships can benefit from mid-course adjustments as they develop and evolve. Our alliance management team makes sure that happens and that the ongoing needs of both partners are always considered and addressed.
Business Development Team
Noven Pharmaceuticals, Inc.
Empire State Building
350 Fifth Avenue
New York, NY 10118